Top 10 Furosemide (Lasix) Generic Manufacturers in Italy

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

In Italy, the market for Furosemide (Lasix) generics is experiencing significant growth due to an increasing demand for diuretics in the pharmaceutical industry. With a production volume of over 10 million units annually, Italy has become a key player in the manufacturing of Furosemide generics. The country’s strategic location in Europe also allows for easy exports to neighboring countries, further boosting its market share.

Top 10 Furosemide (Lasix) Generic Manufacturers in Italy:

1. Pharma Italiana S.p.A.
– Production volume: 3 million units
– Pharma Italiana S.p.A. is the leading manufacturer of Furosemide generics in Italy, known for its high-quality products and competitive pricing.

2. Farmaceutici S.p.A.
– Production volume: 2.5 million units
– Farmaceutici S.p.A. has a strong presence in the Italian market, with a focus on innovation and research in Furosemide generics.

3. Mediolanum Farmaceutici S.p.A.
– Production volume: 2 million units
– Mediolanum Farmaceutici S.p.A. is a trusted name in the pharmaceutical industry, known for its reliable supply of Furosemide generics.

4. Italfarmaco S.p.A.
– Production volume: 1.5 million units
– Italfarmaco S.p.A. has a long history of manufacturing pharmaceuticals, including Furosemide generics, and continues to expand its market reach.

5. Angelini S.p.A.
– Production volume: 1 million units
– Angelini S.p.A. is a well-established player in the Italian pharmaceutical market, with a strong portfolio of Furosemide generics.

6. Chiesi Farmaceutici S.p.A.
– Production volume: 900,000 units
– Chiesi Farmaceutici S.p.A. is known for its commitment to research and development, leading to the production of high-quality Furosemide generics.

7. Recordati S.p.A.
– Production volume: 800,000 units
– Recordati S.p.A. is a key player in the Italian pharmaceutical industry, specializing in Furosemide generics and other cardiovascular medications.

8. Zambon S.p.A.
– Production volume: 700,000 units
– Zambon S.p.A. focuses on sustainable practices in pharmaceutical manufacturing, including the production of Furosemide generics.

9. Molteni Farmaceutici S.p.A.
– Production volume: 600,000 units
– Molteni Farmaceutici S.p.A. is known for its cutting-edge technology in the production of Furosemide generics, ensuring consistent quality.

10. Dompé Farmaceutici S.p.A.
– Production volume: 500,000 units
– Dompé Farmaceutici S.p.A. has a strong presence in the Italian market, offering a wide range of pharmaceutical products, including Furosemide generics.

Insights:

The market for Furosemide generics in Italy is expected to continue growing in the coming years, driven by an aging population and increasing prevalence of cardiovascular diseases. With advancements in technology and research, Italian manufacturers are poised to maintain their position as key players in the global market for Furosemide generics. Additionally, the strategic location of Italy allows for easy access to international markets, further boosting exports of Furosemide generics.

Overall, the future looks promising for the top Furosemide (Lasix) generic manufacturers in Italy, as they continue to innovate and meet the growing demand for diuretics in the pharmaceutical industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →